Financial News
Soligenix Inc (NQ: SNGX )
4.090
-0.150
(-3.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Soligenix Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240709142050_positive-study-update-sends-soligenix-inc.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://spotlightgrowth.com/wp-content/uploads/2023/05/Soligenix-NASDAQ-SNGX-Clinical-Results-Compatability-Study-HyBryte-Spotlight-Growth.jpg)
Via Spotlight Growth
Exposures
Product Safety
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks
February 16, 2023
Via NewMediaWire
Topics
Death
Exposures
Death
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory
November 16, 2022
Via NewMediaWire
Exposures
Product Safety
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Soligenix Proof of Concept Uncovers Potential Treatment Option for the World's 125 Million Psoriasis Sufferers
November 30, 2021
Via NewMediaWire
Exposures
Product Safety
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.